Materials and Process Development for Hybrid Therapeutics | AIChE

Materials and Process Development for Hybrid Therapeutics

Chair(s)

Aytar, S., Bristol-Myers Squibb

Co-chair(s)

Bhebe, P., Amgen

This session is focused on the recent advances and challenges in the discovery, development and manufacturing of antibody drug conjugates (ADCs) and other hybrid therapeutics. The topics to be discussed include advances in protein optimization and expression, conjugation, purification and formulation strategies, advances and challenges in the development of robust and scalable processes, implementation of Process Analytical Technologies (PAT) for process monitoring, and utilization of single-use technologies in manufacturing.

Presentations

Checkout

Paper abstracts are public but to access Extended Abstracts, you must first purchase the conference proceedings.

Checkout

Do you already own this?

Pricing

Individuals

2016 AIChE Annual Meeting
AIChE Pro Members $150.00
AIChE Graduate Student Members Free
AIChE Undergraduate Student Members Free
AIChE Explorer Members $225.00
Non-Members $225.00
Pharmaceutical Discovery, Development and Manufacturing Forum only
AIChE Pro Members $100.00
Food, Pharmaceutical & Bioengineering Division Members Free
AIChE Graduate Student Members Free
AIChE Undergraduate Student Members Free
AIChE Explorer Members $150.00
Non-Members $150.00